{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:03:37Z","timestamp":1790111017075,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jbc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jbc.2026.113373","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T23:57:05Z","timestamp":1785283025000},"page":"113373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Enhanced HLA stability of a heteroclitic WT1 vaccine exacts a kinetic penalty in recognition by a natural TCR"],"prefix":"10.1016","volume":"302","author":[{"given":"Min","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-2682-895X","authenticated-orcid":false,"given":"Peiluan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaopeng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0002-9439","authenticated-orcid":false,"given":"Pengcheng","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbc.2026.113373_bib1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.coi.2008.04.009","article-title":"WT1 peptide vaccine for the treatment of cancer","volume":"20","author":"Oka","year":"2008","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jbc.2026.113373_bib2","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1158\/1078-0432.CCR-09-0737","article-title":"The prioritization of cancer antigens: a national cancer institute pilot project for the acceleration of translational research","volume":"15","author":"Cheever","year":"2009","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.113373_bib3","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1038\/s41591-019-0472-9","article-title":"T cell receptor gene therapy targeting WT1 prevents acute myeloid leukemia relapse post-transplant","volume":"25","author":"Chapuis","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.jbc.2026.113373_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005661","article-title":"Targeting the intracellular WT1 oncogene product with a therapeutic human antibody","volume":"5","author":"Dao","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jbc.2026.113373_bib5","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jmb.2015.12.002","article-title":"Structure of a TCR-mimic antibody with target predicts pharmacogenetics","volume":"428","author":"Ataie","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.113373_bib6","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1172\/JCI130562","article-title":"Specificity of bispecific T cell receptors and antibodies targeting peptide-HLA","volume":"130","author":"Holland","year":"2020","journal-title":"J. Clin. Invest"},{"key":"10.1016\/j.jbc.2026.113373_bib7","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1016\/j.molimm.2010.06.005","article-title":"Structures of native and affinity-enhanced WT1 epitopes bound to HLA-A\u22170201: implications for WT1-based cancer therapeutics","volume":"47","author":"Borbulevych","year":"2010","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jbc.2026.113373_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/cti.2017.4","article-title":"Understanding CD8(+) T-cell responses toward the native and alternate HLA-A\u221702:01-restricted WT1 epitope","volume":"6","author":"Nguyen","year":"2017","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.jbc.2026.113373_bib9","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev-cancerbio-061521-082114","article-title":"Targeting driver oncogenes and other public neoantigens using T cell receptor-based cellular therapy","volume":"7","author":"Martinov","year":"2023","journal-title":"Annu. Rev. Cancer Biol."},{"key":"10.1016\/j.jbc.2026.113373_bib10","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1056\/NEJMoa1012863","article-title":"gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma","volume":"364","author":"Schwartzentruber","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jbc.2026.113373_bib11","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1200\/JCO.2006.10.3465","article-title":"Vaccination of patients with advanced non-small-cell lung cancer with an optimized cryptic human telomerase reverse transcriptase peptide","volume":"25","author":"Bolonaki","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbc.2026.113373_bib12","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1073\/pnas.0800080105","article-title":"Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen","volume":"105","author":"Speiser","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113373_bib13","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2100588118","article-title":"Structures suggest an approach for converting weak self-peptide tumor antigens into superagonists for CD8 T cells in cancer","volume":"118","author":"Wei","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113373_bib14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1084\/jem.20042323","article-title":"Structural and kinetic basis for heightened immunogenicity of T cell vaccines","volume":"201","author":"Chen","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jbc.2026.113373_bib15","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2018125118","article-title":"Structurally silent peptide anchor modifications allosterically modulate T cell recognition in a receptor-dependent manner","volume":"118","author":"Smith","year":"2021","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113373_bib16","doi-asserted-by":"crossref","first-page":"8951","DOI":"10.1074\/jbc.M115.707414","article-title":"A molecular switch abrogates glycoprotein 100 (gp100) T-cell receptor (TCR) targeting of a human melanoma antigen","volume":"291","author":"Bianchi","year":"2016","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113373_bib17","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/10428190802578478","article-title":"Enhancement of lytic activity of leukemic cells by CD8+ cytotoxic T lymphocytes generated against a WT1 peptide analogue","volume":"50","author":"Al Qudaihi","year":"2009","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jbc.2026.113373_bib18","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1038\/sj.leu.2404380","article-title":"Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein","volume":"20","author":"Pinilla-Ibarz","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.jbc.2026.113373_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1182\/blood-2009-10-250993","article-title":"Vaccination with synthetic analog peptides derived from WT1 oncoprotein induces T-cell responses in patients with complete remission from acute myeloid leukemia","volume":"116","author":"Maslak","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.113373_bib20","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s00262-010-0871-8","article-title":"WT1 peptide vaccinations induce CD4 and CD8 T cell immune responses in patients with mesothelioma and non-small cell lung cancer","volume":"59","author":"Krug","year":"2010","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jbc.2026.113373_bib21","doi-asserted-by":"crossref","first-page":"7483","DOI":"10.1158\/1078-0432.CCR-17-2169","article-title":"A randomized phase II trial of adjuvant Galinpepimut-S, WT-1 analogue peptide vaccine, after multimodality therapy for patients with malignant pleural mesothelioma","volume":"23","author":"Zauderer","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jbc.2026.113373_bib22","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1182\/bloodadvances.2017014175","article-title":"Phase 2 trial of a multivalent WT1 peptide vaccine (galinpepimut-S) in acute myeloid leukemia","volume":"2","author":"Maslak","year":"2018","journal-title":"Blood Adv."},{"key":"10.1016\/j.jbc.2026.113373_bib23","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1182\/blood.2020010477","article-title":"Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody","volume":"138","author":"Augsberger","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.jbc.2026.113373_bib24","doi-asserted-by":"crossref","first-page":"12275","DOI":"10.1073\/pnas.182418399","article-title":"Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor cells","volume":"99","author":"Hernandez","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113373_bib25","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/JLB.5MA0922-749R","article-title":"Altered MUC1 epitope-specific CTLs: a potential target for immunotherapy of pancreatic cancer","volume":"112","author":"Hong","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jbc.2026.113373_bib26","article-title":"Identification and enhancement of HLA-A2.1-restricted CTL epitopes in a new human cancer antigen-POTE","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jbc.2026.113373_bib27","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1002\/1521-4141(2000012)30:12<3411::AID-IMMU3411>3.0.CO;2-R","article-title":"A general strategy to enhance immunogenicity of low-affinity HLA-A2. 1-associated peptides: implication in the identification of cryptic tumor epitopes","volume":"30","author":"Tourdot","year":"2000","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jbc.2026.113373_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1146\/annurev-biochem-011520-102754","article-title":"HLAs, TCRs, and KIRs, a triumvirate of human cell-mediated immunity","volume":"89","author":"Djaoud","year":"2020","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.jbc.2026.113373_bib29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/cei.12570","article-title":"T cell receptor binding affinity governs the functional profile of cancer-specific CD8+ T cells","volume":"180","author":"Tan","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jbc.2026.113373_bib30","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92570","article-title":"TCR-ligand dissociation rate is a robust and stable biomarker of CD8+ T cell potency","volume":"2","author":"Allard","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.jbc.2026.113373_bib31","doi-asserted-by":"crossref","first-page":"23068","DOI":"10.1074\/jbc.M112.357673","article-title":"Interplay between T cell receptor binding kinetics and the level of cognate peptide presented by major histocompatibility complexes governs CD8+ T cell responsiveness","volume":"287","author":"Irving","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.jbc.2026.113373_bib32","doi-asserted-by":"crossref","first-page":"8724","DOI":"10.1073\/pnas.1000966107","article-title":"Fast on-rates allow short dwell time ligands to activate T cells","volume":"107","author":"Govern","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jbc.2026.113373_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141681","article-title":"Biochemical and structural insights into position 97 micropolymorphisms in human leukocyte antigen (HLA)-C\u221712 allotypes and their differential disease associations","volume":"306","author":"Yang","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jbc.2026.113373_bib34","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1111\/cas.70048","article-title":"Features of HLA-A\u221702 in identifying eligible patients for tecelra TCR-T therapy","volume":"116","author":"Yang","year":"2025","journal-title":"Cancer Sci."},{"key":"10.1016\/j.jbc.2026.113373_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.142772","article-title":"Micropolymorphism outside the peptide-binding groove of human leukocyte antigen (HLA)-C\u221714 modulates structural stability and shapes immune responses","volume":"309","author":"Liu","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jbc.2026.113373_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1107\/S0907444910048675","article-title":"iMOSFLM: a new graphical interface for diffraction-image processing with MOSFLM","volume":"67","author":"Battye","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2026.113373_bib37","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1107\/S0907444910045749","article-title":"Overview of the CCP4 suite and current developments","volume":"67","author":"Winn","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2026.113373_bib38","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1107\/S0021889807021206","article-title":"Phaser crystallographic software","volume":"40","author":"McCoy","year":"2007","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.jbc.2026.113373_bib39","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2026.113373_bib40","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1107\/S0907444902016657","article-title":"PHENIX: building new software for automated crystallographic structure determination","volume":"58","author":"Adams","year":"2002","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"10.1016\/j.jbc.2026.113373_bib41","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/pro.3943","article-title":"UCSF ChimeraX: structure visualization for researchers, educators, and developers","volume":"30","author":"Pettersen","year":"2021","journal-title":"Protein Sci."},{"key":"10.1016\/j.jbc.2026.113373_bib42","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.jmb.2007.05.022","article-title":"Inference of macromolecular assemblies from crystalline State","volume":"372","author":"Krissinel","year":"2007","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jbc.2026.113373_bib43","doi-asserted-by":"crossref","first-page":"5323","DOI":"10.1093\/bioinformatics\/btz517","article-title":"TCR3d: the T cell receptor structural repertoire database","volume":"35","author":"Gowthaman","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jbc.2026.113373_bib44","doi-asserted-by":"crossref","first-page":"D604","DOI":"10.1093\/nar\/gkae840","article-title":"TCR3d 2.0: expanding the T cell receptor structure database with new structures, tools and interactions","volume":"53","author":"Lin","year":"2025","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jbc.2026.113373_bib45","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cell.2014.04.048","article-title":"Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity","volume":"158","author":"Clayton","year":"2014","journal-title":"Cell"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826022453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925826022453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T20:02:04Z","timestamp":1790107324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925826022453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0021925826022453"],"URL":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113373","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enhanced HLA stability of a heteroclitic WT1 vaccine exacts a kinetic penalty in recognition by a natural TCR","name":"articletitle","label":"Article Title"},{"value":"Journal of Biological Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbc.2026.113373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc on behalf of American Society for Biochemistry and Molecular Biology.","name":"copyright","label":"Copyright"}],"article-number":"113373"}}